0000899243-18-031133.txt : 20181214 0000899243-18-031133.hdr.sgml : 20181214 20181214201247 ACCESSION NUMBER: 0000899243-18-031133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181212 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maduck Sean CENTRAL INDEX KEY: 0001698310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 181236820 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-12 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001698310 Maduck Sean C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 See Remarks Common Stock 2018-12-12 4 M 0 44991 2.61 A 65015 D Common Stock 2018-12-12 4 M 0 15009 3.29 A 80024 D Common Stock 2018-12-12 4 S 0 60000 19.0061 D 20024 D Common Stock 2018-12-13 4 M 0 10000 2.24 A 30024 D Common Stock 10000 I See Footnote Common Stock 10000 I See Footnote Stock Option (Right to Buy) 2.61 2018-12-12 4 M 0 44991 0.00 D 2024-08-07 Common Stock 44991 55009 D Stock Option (Right to Buy) 3.29 2018-12-12 4 M 0 15009 0.00 D 2025-02-18 Common Stock 15009 234991 D Stock Option (Right to Buy) 2.24 2018-12-13 4 M 0 10000 0.00 D 2022-11-01 Common Stock 10000 25000 D Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein. Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee. Fully exercisable. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 18, 2015, so that the total number of shares subject to this option becomes fully vested and exercisable on February 18, 2019. Senior Vice President, Commercial /s/ Sean Nicholas Maduck 2018-12-14